2026.08.21
YouTube
【対談】眼科医有田玲子先生に伺う、坪田ラボが挑むマイボーム腺機能不全治療薬候補「TLM-001」の可能性
[Interview] Dr. Reiko Arita, Ophthalmologist, Discusses the Potential of “TLM-001,” a Candidate Drug for Meibomian Gland Dysfunction Being Developed by the Tsubota Lab
Financial Results Briefing for the First Quarter of the Fiscal Year Ending March 2027
2027年3月期第1四半期決算説明
[ReLight Tech] Here’s a look at our display prototype!